After an initial five year period in the food industry, Le Roy returned to academic studies; he holds a BSc (Hons) in Biochemistry from Queen’s University Belfast and obtained his PhD in Nutritional Biochemistry studying the effects of nutrition on the immune function in adult Cystic Fibrosis patients at Ulster University in 2003. Le Roy held a number of Post-Doctoral research positions within the Biomedical Sciences Research Institute (BMSRI) before being appointed as the Institute’s Quality Assurance Officer (QAO). Whilst employed as a QAO he set up and developed the Core Facility Units which support academic and commercial research. In February 2015 he was appointed Commercial Manager at C-TRIC (Clinical Translational Research Innovation Centre) where he has worked closely with the Western Health and Social Care Trust, Ulster University, DCSDC, NWRC, lnvestNI, and local companies, entrepreneurs and agencies to develop economic growth and supply bio-business support and advice. Dr Dowey was then appointed as the Business Development Manager at Ulster University’s BMSRI where he managed an expert team of Scientific Assistants/Officers and the Core Facility Units within the institute.
Le Roy joined the GreenLight Team in June 2018 as Director of Corporate Development and has now moved to the position of Chief Operations Officer.
He was awarded a prestigious fellowship in 2010 by Arthritis Research UK to perform diagnostics research in the University of Colorado, Denver, USA. He holds a PhD from Queen’s University Belfast, awarded in 2001 for work on drugs to reduce spread of brain cancers.
In his role as Chief Scientific Officer he oversees the translation of lab based research, via rigorous clinical trials, to novel treatments for a wide range of chronic conditions. His personal research focus with GreenLight Medicines is to identify phytocannabinoids which reduce pain and inflammatory signalling most effectively, in collaboration with Ulster University.